Filing Flows › Korsana Biosciences (KRSA) › Q4 2025 › vs Q4 2024
Korsana Biosciences (KRSA) Q4 2025 vs Q4 2024 (year over year)
Korsana Biosciences's revenue fell $781K (-43%) from $1.8M in Q4 2024 to $1.0M in Q4 2025.
Korsana Biosciences, Q4 2025: revenue $1.0M (-43% year over year), operating margin -81.8%, net loss $799K, operating cash flow −$1.6M. The chart draws each line against Q4 2024, the increases inside each band.
Every line
| Line | Q4 2025 | Q4 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $1.0M | $1.8M | −$781K | -43% |
| Other income, net | $39K | $28K | $11K | +39% |
| Net loss | $799K | −$530K | $1.3M | — |
| Costs & expenses | $1.9M | $1.8M | $29K | +2% |
| Operating costs | $1.9M | $1.3M | $559K | +43% |
| Research & development | $519K | $56K | $463K | +827% |
| General & admin | $1.3M | $1.2M | $96K | +8% |
| Operating cash sources | $1.7M | −$238K | $1.9M | — |
| Share-based compensation | $95K | $122K | −$27K | -22% |
| Cash used in operations | $1.6M | −$360K | $1.9M | — |
| Net loss absorbed | $799K | −$530K | $1.3M | — |
| Working capital & other | $875K | $292K | $583K | +200% |
Questions
How much did Korsana Biosciences's revenue grow year over year in Q4 2025?
Korsana Biosciences's revenue fell $781K (-43%) from $1.8M in Q4 2024 to $1.0M in Q4 2025.